Search results
AstraZeneca Gets Workers’ Covid-19 Faith Bias Suit Narrowed
Bloomberg Law· 2 days ago‘s bid to dismiss some claims from workers who asserted religious objections to its Covid-19 vaccination mandate proved successful when a federal court ...
Novel AI method could improve tissue and tumour analysis
Digital Journal· 11 hours agoThe technique is described as ‘Integrative and Reference-Informed tissue Segmentation’, or IRIS.
Novavax Stock Rallies In Pre-Market As Company Plans To Deliver Covid-19 Vaccine By September -...
Benzinga· 2 days agoNovavax Inc. NVAX shares surged after the company announced its plans to deliver a...
Summit Therapeutics, AstraZeneca And More From The Year’s Biggest Cancer Conference
Forbes· 2 days agoThe American Society of Clinical Oncology held its annual conference in Chicago this past week,...
'Outstanding' Results for Osimertinib: Stage III EGFR+ NSCLC
Medscape· 4 days agoResults from the LAURA trial will change practice once its label gets expanded, experts said at the...
'Practice Changing' Trial for Inoperable Locally Advanced NSCLC
MedPage Today· 6 days agoEGFR testing now needed for all patients with stage III disease, experts say
Is Semaglutide the
Medscape· 5 days agoThere has been much hyperbole since the presentation of results from the SELECT cardiovascular outcomes trial (CVOT) at this year's European Congress on...
Can Chemo Benefit Older Patients With Pancreatic Cancer?
Medscape· 1 day agoBetter tools are needed to identify vulnerable older patients with metastatic pancreatic cancer who...
FDA panel rejects MDMA therapy for treating patients with PTSD
WSB Radio· 3 days agoAn independent advisory panel of the Food and Drug Administration on Tuesday rejected the use of...
Improved Outcomes With Subcutaneous Amivantamab in NSCLC
Medscape· 6 days agoSubcutaneous amivantamab plus lazertinib may offer a survival benefit over intravenous administration, alongside dramatically reduced administration times, a new study suggests.